Your browser doesn't support javascript.
loading
Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC.
Herbst, Roy S; Arkenau, Hendrik Tobias; Bendell, Johanna; Arrowsmith, Edward; Wermke, Martin; Soriano, Andres; Penel, Nicolas; Santana-Davila, Rafael; Bischoff, Helge; Chau, Ian; Mi, Gu; Wang, Hong; Rasmussen, Erik; Ferry, David; Chao, Bo H; Paz-Ares, Luis.
Afiliação
  • Herbst RS; Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut. Electronic address: Roy.Herbst@yale.edu.
  • Arkenau HT; Drug Development Unit, Sarah Cannon Research Institute United Kingdom, London, United Kingdom; Cancer Institute, University College London, London, United Kingdom.
  • Bendell J; Drug Development Unit, Tennessee Oncology/Sarah Cannon Research Institute, Nashville, Tennessee.
  • Arrowsmith E; Tennessee Oncology/Sarah Cannon Research Institute, Chattanooga, Tennessee.
  • Wermke M; NCT/UCC-ECTU, Medical Faculty Carl Gustav Carus, Technical University, Dresden, Germany.
  • Soriano A; Florida Cancer Specialists/Sarah Cannon Research Institute, Englewood, Florida.
  • Penel N; Centre Oscar Lambret, Lille University, Lille, France.
  • Santana-Davila R; Department of Medicine, University of Washington, Seattle, Washington.
  • Bischoff H; Department of Thoracic Oncology, Thoraxklinik Heidelberg, Heidelberg, Germany.
  • Chau I; Department of Medicine, Royal Marsden Hospital, London and Surrey, United Kingdom.
  • Mi G; Eli Lilly and Company, Indianapolis, Indiana.
  • Wang H; Eli Lilly and Company, Indianapolis, Indiana.
  • Rasmussen E; Eli Lilly and Company, New York, New York.
  • Ferry D; Eli Lilly and Company, New York, New York.
  • Chao BH; Eli Lilly and Company, New York, New York.
  • Paz-Ares L; CNIO-H12o Lung Cancer Unit, Hospital Universitario 12 de Octubre, Universidad Complutense & CIBERONC, Madrid, Spain.
J Thorac Oncol ; 16(2): 289-298, 2021 02.
Article em En | MEDLINE | ID: mdl-33068794

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article